Pine Pharmaceuticals, Llc
Tonawanda, NY, United States
This page shows every FDA and USDA recall linked to Pine Pharmaceuticals, Llc. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
6
Total Recalls
2015
First Recall
2023
Most Recent
Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by:...
Oct 25, 2023
· Drug
Class II
Terminated
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplie...
Apr 19, 2023
· Drug
Class III
Terminated
Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial,...
Jan 11, 2023
· Drug
Class II
Terminated
Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged...
Sep 21, 2022
· Drug
Class II
Terminated
Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Rive...
Mar 28, 2018
· Drug
Class III
Terminated
Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Phar...
Jan 27, 2016
· Drug
Class II
Terminated